Search research articles
Contact Us
Filters
Showing results (201-210 of 228) with videos related to
Page
of 23
Sort By:
Nature Medicine
|
August 8, 2022
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
Rupert Bartsch, Anna Sophie Berghoff, Julia Furtner, et al.
Cancer Medicine
|
March 22, 2022
The cancer survival index-A prognostic score integrating psychosocial and biological factors in patients diagnosed with cancer or haematologic malignancies
Alexander Gaiger, Simone Lubowitzki, Katharina Krammer, et al.
NPJ Breast Cancer
|
December 20, 2025
Novel treatment strategies and key research priorities for patients with breast cancer and central nervous system (CNS) metastases
Katarzyna J Jerzak, Evangelia D Razis, Elisa Agostinetto, et al.
The Oncologist
|
June 9, 2021
Clinicopathologic and Genomic Landscape of Breast Carcinoma Brain Metastases
Richard S P Huang, James Haberberger, Kimberly McGregor, et al.
The Lancet. Oncology
|
October 30, 2025
Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of breast cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trial
Rupert Bartsch, Maximilian Marhold, Javier Garde-Noguera, et al.
Breast (Edinburgh, Scotland)
|
June 29, 2026
Tucatinib in patients with HER2-positive advanced/metastatic breast cancer: A systematic literature review of real-world evidence
Rodrigo Sanchez-Bayona, Carey Anders, Rupert Bartsch, et al.
Nature Medicine
|
May 30, 2025
Patritumab deruxtecan in leptomeningeal metastatic disease of solid tumors: the phase 2 TUXEDO-3 trial
Matthias Preusser, Javier Garde-Noguera, Juan José García-Mosquera, et al.
British Journal of Cancer
|
March 25, 2021
Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34
Rupert Bartsch, Christian F Singer, Georg Pfeiler, et al.
ESMO Open
|
August 28, 2020
Oncological care organisation during COVID-19 outbreak
Concetta Elisa Onesti, Hope S Rugo, Daniele Generali, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 24, 2020
Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34)
Christian F Singer, Georg Pfeiler, Michael Hubalek, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 228) with videos related to
Sort By:
Page
of 23
Nature Medicine
|
August 8, 2022
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
Rupert Bartsch, Anna Sophie Berghoff, Julia Furtner, et al.
Cancer Medicine
|
March 22, 2022
The cancer survival index-A prognostic score integrating psychosocial and biological factors in patients diagnosed with cancer or haematologic malignancies
Alexander Gaiger, Simone Lubowitzki, Katharina Krammer, et al.
NPJ Breast Cancer
|
December 20, 2025
Novel treatment strategies and key research priorities for patients with breast cancer and central nervous system (CNS) metastases
Katarzyna J Jerzak, Evangelia D Razis, Elisa Agostinetto, et al.
The Oncologist
|
June 9, 2021
Clinicopathologic and Genomic Landscape of Breast Carcinoma Brain Metastases
Richard S P Huang, James Haberberger, Kimberly McGregor, et al.
The Lancet. Oncology
|
October 30, 2025
Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of breast cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trial
Rupert Bartsch, Maximilian Marhold, Javier Garde-Noguera, et al.
Breast (Edinburgh, Scotland)
|
June 29, 2026
Tucatinib in patients with HER2-positive advanced/metastatic breast cancer: A systematic literature review of real-world evidence
Rodrigo Sanchez-Bayona, Carey Anders, Rupert Bartsch, et al.
Nature Medicine
|
May 30, 2025
Patritumab deruxtecan in leptomeningeal metastatic disease of solid tumors: the phase 2 TUXEDO-3 trial
Matthias Preusser, Javier Garde-Noguera, Juan José García-Mosquera, et al.
British Journal of Cancer
|
March 25, 2021
Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34
Rupert Bartsch, Christian F Singer, Georg Pfeiler, et al.
ESMO Open
|
August 28, 2020
Oncological care organisation during COVID-19 outbreak
Concetta Elisa Onesti, Hope S Rugo, Daniele Generali, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 24, 2020
Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34)
Christian F Singer, Georg Pfeiler, Michael Hubalek, et al.
Page
of 23